Oric Pharmaceuticals director Heyman sells $86,524 in ORIC stock
Covered in this story
Call it yourself
No calls on $ORIC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Oric Pharmaceuticals Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.